Related references
Note: Only part of the references are listed.Ovarian carcinosarcoma is a distinct form of ovarian cancer with poorer survival compared to tubo-ovarian high-grade serous carcinoma
Robert L. Hollis et al.
BRITISH JOURNAL OF CANCER (2022)
Secondary cytoreduction followed by chemotherapy versus chemotherapy alone in platinum-sensitive relapsed ovarian cancer (SOC-1): a multicentre, open-label, randomised, phase 3 trial
Tingyan Shi et al.
LANCET ONCOLOGY (2021)
Randomized phase III study to evaluate the impact of secondary cytoreductive surgery in recurrent ovarian cancer: Final analysis of AGO DESKTOP III/ENGOT-ov20.
Andreas Du Bois et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A randomized phase 3 trial of paclitaxel (P) plus carboplatin (C) versus paclitaxel plus ifosfamide (I) in chemotherapy-naive patients with stage I-IV, persistent or recurrent carcinosarcoma of the uterus or ovary: An NRG Oncology trial.
Matthew A. Powell et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Secondary Surgical Cytoreduction for Recurrent Ovarian Cancer
Robert L. Coleman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Overall Survival and Adjuvant Therapy in Women with Ovarian Carcinosarcoma: A Single-Institution Experience
Aaron Nizam et al.
DIAGNOSTICS (2019)
Carcinosarcoma of the ovary compared to ovarian high-grade serous carcinoma: impact of optimal cytoreduction and standard adjuvant treatment
Ibrahim Yalcin et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2018)
Comparison of first-line chemotherapy regimens for ovarian carcinosarcoma: a single institution case series and review of the literature
Melissa Brackmann et al.
BMC CANCER (2018)
Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
W. J. van Driel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Multi-institutional study of peritoneal sarcomatosis from uterine sarcoma treated with cytoreductive surgery and hyperthermic intraperitoneal chemotherapy
Armando Sardi et al.
EJSO (2017)
Long-Term Survival Advantage and Prognostic Factors Associated With Intraperitoneal Chemotherapy Treatment in Advanced Ovarian Cancer: A Gynecologic Oncology Group Study
Devansu Tewari et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
FIGO's staging classification for cancer of the ovary, fallopian tube, and peritoneum: abridged republication
Jaime Prat
JOURNAL OF GYNECOLOGIC ONCOLOGY (2015)
Gynecologic Cancer InterGroup (GCIG) Consensus Review for Uterine and Ovarian Carcinosarcoma
Dominique Berton-Rigaud et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2014)
Carcinosarcoma of the ovary: Natural history, patterns of treatment, and outcome
Erin M. George et al.
GYNECOLOGIC ONCOLOGY (2013)
Carcinosarcoma of the ovary: A review of the literature
Marcela G. del Carmen et al.
GYNECOLOGIC ONCOLOGY (2012)
Neoplasms of the Appendix Current Treatment Guidelines
Suven Shankar et al.
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA (2012)
Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
Jaime Prat
VIRCHOWS ARCHIV (2012)
Does hyperthermic intraoperative chemotherapy lead to improved outcomes in patients with ovarian cancer? A single center cohort study in 111 consecutive patients
Rene Warschkow et al.
PATIENT SAFETY IN SURGERY (2012)
Carcinosarcoma of the ovary: A case-control study
J. Alejandro Rauh-Hain et al.
GYNECOLOGIC ONCOLOGY (2011)
The Clavien-Dindo Classification of Surgical Complications Five-Year Experience
Pierre A. Clavien et al.
ANNALS OF SURGERY (2009)
Carcinosarcoma of the ovary treated with platinum and taxane: The memorial Sloan-Kettering Cancer Center experience
Aliza L. Leiser et al.
GYNECOLOGIC ONCOLOGY (2007)
New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?
PH Sugarbaker
LANCET ONCOLOGY (2006)
Carcinosarcoma of the ovary - a case series
TL Rutledge et al.
GYNECOLOGIC ONCOLOGY (2006)
Paclitaxel and platinum chemotherapy for malignant mixed mullerian tumors of the ovary
LR Duska et al.
GYNECOLOGIC ONCOLOGY (2002)